Mostafa Kamal, CEO, Magellan Rx Management at MAGELLAN HEALTH INC (MGLN), sold 9,696 shares at $85.76 ($832K) on 2017-09-28, disclosed to the SEC on 2017-09-29.
Open-market sale of $832k MGLN by CEO, Magellan Rx Management. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.76 | 4,848 | $416K | 50.0% |
| 2 | $85.76 | 4,848 | $416K | 50.0% |
| Total | $85.76 avg | 9,696 | $832K | 100% |
| Filing → |
| MGLN | SELL | 2020-11-12 | $979K | — | Filing → |
| MGLN | SELL | 2020-11-06 | $1.1M | — | Filing → |
| MGLN | SELL | 2020-10-20 | $15K | — | Filing → |